Stockscreener 앱 받기
1.22
5.17%
0.06
시간 외 거래:
1.23
0.01
+0.82%
전일 마감가:
$1.16
열려 있는:
$1.14
하루 거래량:
119.78K
Relative Volume:
0.23
시가총액:
$56.96M
수익:
$13.18M
순이익/손실:
$-9.65M
주가수익비율:
-6.4076
EPS:
-0.1904
순현금흐름:
$-8.58M
1주 성능:
-6.87%
1개월 성능:
-12.23%
6개월 성능:
-29.48%
1년 성능:
+0.00%
1일 변동 폭
$1.12
$1.23
1주일 범위
$1.12
$1.40
52주 변동 폭
$1.015
$2.99
Mindwalk Holdings Corp Stock (HYFT) Company Profile
Compare HYFT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYFT
Mindwalk Holdings Corp
|
1.22 | 54.16M | 13.18M | -9.65M | -8.58M | -0.1904 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-12-02 | 개시 | H.C. Wainwright | Buy |
| 2021-10-25 | 개시 | The Benchmark Company | Buy |
Mindwalk Holdings Corp 주식(HYFT)의 최신 뉴스
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) Q3 2026 earnings call transcript - MSN
Benchmark reiterates Speculative Buy on MindWalk Holdings stock By Investing.com - Investing.com Canada
Benchmark reiterates Speculative Buy on MindWalk Holdings stock - Investing.com
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2026 Earnings Call Transcript - Insider Monkey
H.C. Wainwright reiterates Buy on MindWalk stock on SaaS deal - Investing.com Nigeria
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts By GuruFocus - Investing.com Canada
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts - GuruFocus
MindWalk Holdings Corp. (HYFT) reports Q3 loss, lags revenue estimates - MSN
MindWalk Holdings Corp. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:HYFT) 2026-03-12 - Seeking Alpha
MindWalk Holdings Corp. Q3 2026 Earnings Call Summary - Yahoo Finance
MindWalk (HYFT) Q3 2026 Earnings Call Transcript - The Globe and Mail
HYFT: Q3 revenue up 52% YoY, recurring LensAI contract signed, and pipeline programs advanced - TradingView
MindWalk Holdings Corp. (HYFT) Posts Third Quarter Loss, Falls Short of Revenue Expectations - Bitget
HYFT: Q3 FY 2026 revenue rose 52% YoY, with first enterprise contract and $14.2M cash on hand - TradingView
Q3 2026 MindWalk Holdings Corp Earnings Call Transcript - GuruFocus
MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
MindWalk Holdings Corp reports results for the quarter ended January 31Earnings Summary - TradingView
MindWalk Holdings Delivers Q3 Revenue Surge and Secures First LensAI Platform Contract - TipRanks
HYFT: Q3 revenue up 52% to $4.2M, with recurring contracts and pipeline progress boosting outlook - TradingView
MindWalk Holdings (NASDAQ: IPA) grows revenue 45% and boosts margins amid AI pivot - Stock Titan
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results - The Joplin Globe
MindWalk Holdings Corp. (Nasdaq: HYFT) posts 52% Q3 revenue growth - Stock Titan
AI biotech MindWalk targets dengue, obesity and flu with llama nanobodies - Stock Titan
HYFT Forecast, Price Target & Analyst Ratings | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill
MindWalk Holdings emphasizes AI-driven strategy in latest financial release - MSN
MindWalk Holdings Corp PE Ratio (TTM) & PE Ratio (TTM) ChartsHYFT - GuruFocus
MindWalk launches nanobody discovery platform for bispecifics - Investing.com Nigeria
MindWalk Holdings Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
MindWalk launches nanobody discovery platform for bispecifics By Investing.com - Investing.com Australia
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView
MindWalk Announces B Cell Llama(TM), a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era - irw-press.com
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era - The National Law Review
MindWalk (HYFT) Introduces B Cell Llama for Enhanced Antibody Di - GuruFocus
MindWalk Unveils B Cell Llama Nanobody Platform Backed by Peer-Reviewed Study - TipRanks
New MindWalk (NASDAQ: HYFT) B Cell Llama platform targets bispecific and cell therapies - Stock Titan
HYFT SEC FilingsMindWalk Holdings Corp 10-K, 10-Q, 8-K Forms - Stock Titan
MindWalk Holdings to Report Q3 2026 Earnings - National Today
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026 - 01net
MindWalk Sets March 12 Date to Report Q3 2026 Results and Host Earnings Webcast - TipRanks
MindWalk (NASDAQ: IPA) sets March 12 call on Q3 FY 2026 results - Stock Titan
HYFT Technical Analysis & ETF Price Forecast - Intellectia AI
Zacks Research Upgrades MindWalk (NASDAQ:HYFT) to Hold - MarketBeat
Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Business Wire
MindWalk Uses HYFT AI Platform to Expose Hidden Portfolio and IP Risks in Drug Discovery - TipRanks
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Yahoo Finance
MindWalk Launches HYFT Technology to Address Drug Development Risks - intellectia.ai
HYFT Forecast — Price Prediction for 2026. Should I Buy HYFT? - Intellectia AI
After Leaping 47% MindWalk Holdings Corp. (NASDAQ:HYFT) Shares Are Not Flying Under The Radar - 富途牛牛
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - BioSpace
Mindwalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic Tdp-43 in Neurodegenerative Disease - marketscreener.com
Mindwalk Holdings Corp (HYFT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):